Cargando…
The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines
Nanoparticles (NPs) are intensively investigated as adjuvants in new generation vaccines, while how these NPs promote the immune responses has not been well understood. In this research, we have tried to elucidate the possible pathways for layered double hydroxide (LDH) NPs to provoke immune respons...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158326/ https://www.ncbi.nlm.nih.gov/pubmed/30294273 http://dx.doi.org/10.3389/fphar.2018.01060 |
_version_ | 1783358407357497344 |
---|---|
author | Yan, Shiyu Xu, Kewei Li, Li Gu, Wenyi Rolfe, Barbara E. Xu, Zhi P. |
author_facet | Yan, Shiyu Xu, Kewei Li, Li Gu, Wenyi Rolfe, Barbara E. Xu, Zhi P. |
author_sort | Yan, Shiyu |
collection | PubMed |
description | Nanoparticles (NPs) are intensively investigated as adjuvants in new generation vaccines, while how these NPs promote the immune responses has not been well understood. In this research, we have tried to elucidate the possible pathways for layered double hydroxide (LDH) NPs to provoke immune responses. As previously reported, LDH NPs efficiently deliver antigens to antigen presenting cells (APCs). In this research, we have found that these internalized LDH NPs are not released by these APCs within 8 h. We have for the first time found that macrophage cells exchange the internalized LDH NPs with other surrounding ones, which may promote immune responses in an additional way. Moreover, the internalized LDH-antigen NPs significantly facilitate the maturation of immature DCs and enhance cross-presentation of epitope/MHC class I complexes on the DC surface. This research would help understand the NP adjuvant mechanism and further assist the design of new specific NPs as more efficient nano-adjuvants. |
format | Online Article Text |
id | pubmed-6158326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61583262018-10-05 The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines Yan, Shiyu Xu, Kewei Li, Li Gu, Wenyi Rolfe, Barbara E. Xu, Zhi P. Front Pharmacol Pharmacology Nanoparticles (NPs) are intensively investigated as adjuvants in new generation vaccines, while how these NPs promote the immune responses has not been well understood. In this research, we have tried to elucidate the possible pathways for layered double hydroxide (LDH) NPs to provoke immune responses. As previously reported, LDH NPs efficiently deliver antigens to antigen presenting cells (APCs). In this research, we have found that these internalized LDH NPs are not released by these APCs within 8 h. We have for the first time found that macrophage cells exchange the internalized LDH NPs with other surrounding ones, which may promote immune responses in an additional way. Moreover, the internalized LDH-antigen NPs significantly facilitate the maturation of immature DCs and enhance cross-presentation of epitope/MHC class I complexes on the DC surface. This research would help understand the NP adjuvant mechanism and further assist the design of new specific NPs as more efficient nano-adjuvants. Frontiers Media S.A. 2018-09-20 /pmc/articles/PMC6158326/ /pubmed/30294273 http://dx.doi.org/10.3389/fphar.2018.01060 Text en Copyright © 2018 Yan, Xu, Li, Gu, Rolfe and Xu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Yan, Shiyu Xu, Kewei Li, Li Gu, Wenyi Rolfe, Barbara E. Xu, Zhi P. The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines |
title | The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines |
title_full | The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines |
title_fullStr | The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines |
title_full_unstemmed | The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines |
title_short | The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines |
title_sort | pathways for layered double hydroxide nanoparticles to enhance antigen (cross)-presentation on immune cells as adjuvants for protein vaccines |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158326/ https://www.ncbi.nlm.nih.gov/pubmed/30294273 http://dx.doi.org/10.3389/fphar.2018.01060 |
work_keys_str_mv | AT yanshiyu thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT xukewei thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT lili thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT guwenyi thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT rolfebarbarae thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT xuzhip thepathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT yanshiyu pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT xukewei pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT lili pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT guwenyi pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT rolfebarbarae pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines AT xuzhip pathwaysforlayereddoublehydroxidenanoparticlestoenhanceantigencrosspresentationonimmunecellsasadjuvantsforproteinvaccines |